Novel high-performance liquid chromatographic assay using fluorescence detection for the quantitation of plasma γ-methylene-10-deazaaminopterin and its major metabolite, 7-hydroxy-γ-methylene-10 -deazaaminopterin, in patients with solid cancers in a phase I trial

H. Su, T. L. Chen, F. H. Hausheer, E. K. Rowinsky

Research output: Contribution to journalArticle

Abstract

γ-Methylene-10-deazaaminopterin (MDAM), a unique dihydrofolate reductase inhibitor, has demonstrated antitumor activity against a broad spectrum of human solid tumors in preclinical studies. A novel reversed-phase, ion-pair high-performance liquid chromatography (HPLC) assay that uses fluorescence detection has been developed to quantitate levels of MDAM and its major metabolite, 7-hydroxy-γ-methylene-10-deazaaminopterin (7-OH-MDAM), in human plasma. The recovery of MDAM and 7-OH-MDAM from plasma was >97% by a simple one-step deproteinization process using tetrabutylammonium bromide (TBABr) and methanol. MDAM and 7-OH-MDAM remained stable in plasma over a 28-day test period at ambient temperatures, and neither compound was light-sensitive. The limit of quantitation was 0.005 μM for both MDAM and 7-OH-MDAM. This assay has been found to be simple, sensitive and reproducible in determining plasma concentrations of MDAM and 7-OH-MDAM in patients with solid cancers in a phase trial.

Original languageEnglish (US)
Pages (from-to)401-408
Number of pages8
JournalJournal of Chromatography B: Biomedical Applications
Volume695
Issue number2
DOIs
StatePublished - Aug 1 1997
Externally publishedYes

Fingerprint

Metabolites
Assays
Fluorescence
Plasmas
Liquids
10-deazaaminopterin
Plasma (human)
Folic Acid Antagonists
High performance liquid chromatography
Methanol
Tumors
hydroxide ion
Ions
Recovery

Keywords

  • γ-Methylene-10-deazaaminopterin
  • 7-hydroxy-γ-methylene-10-deazaaminopterin

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

@article{952bccdf08084fcbb6def6d7ef90a12b,
title = "Novel high-performance liquid chromatographic assay using fluorescence detection for the quantitation of plasma γ-methylene-10-deazaaminopterin and its major metabolite, 7-hydroxy-γ-methylene-10 -deazaaminopterin, in patients with solid cancers in a phase I trial",
abstract = "γ-Methylene-10-deazaaminopterin (MDAM), a unique dihydrofolate reductase inhibitor, has demonstrated antitumor activity against a broad spectrum of human solid tumors in preclinical studies. A novel reversed-phase, ion-pair high-performance liquid chromatography (HPLC) assay that uses fluorescence detection has been developed to quantitate levels of MDAM and its major metabolite, 7-hydroxy-γ-methylene-10-deazaaminopterin (7-OH-MDAM), in human plasma. The recovery of MDAM and 7-OH-MDAM from plasma was >97{\%} by a simple one-step deproteinization process using tetrabutylammonium bromide (TBABr) and methanol. MDAM and 7-OH-MDAM remained stable in plasma over a 28-day test period at ambient temperatures, and neither compound was light-sensitive. The limit of quantitation was 0.005 μM for both MDAM and 7-OH-MDAM. This assay has been found to be simple, sensitive and reproducible in determining plasma concentrations of MDAM and 7-OH-MDAM in patients with solid cancers in a phase trial.",
keywords = "γ-Methylene-10-deazaaminopterin, 7-hydroxy-γ-methylene-10-deazaaminopterin",
author = "H. Su and Chen, {T. L.} and Hausheer, {F. H.} and Rowinsky, {E. K.}",
year = "1997",
month = "8",
day = "1",
doi = "10.1016/S0378-4347(97)00205-3",
language = "English (US)",
volume = "695",
pages = "401--408",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "0378-4347",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Novel high-performance liquid chromatographic assay using fluorescence detection for the quantitation of plasma γ-methylene-10-deazaaminopterin and its major metabolite, 7-hydroxy-γ-methylene-10 -deazaaminopterin, in patients with solid cancers in a phase I trial

AU - Su, H.

AU - Chen, T. L.

AU - Hausheer, F. H.

AU - Rowinsky, E. K.

PY - 1997/8/1

Y1 - 1997/8/1

N2 - γ-Methylene-10-deazaaminopterin (MDAM), a unique dihydrofolate reductase inhibitor, has demonstrated antitumor activity against a broad spectrum of human solid tumors in preclinical studies. A novel reversed-phase, ion-pair high-performance liquid chromatography (HPLC) assay that uses fluorescence detection has been developed to quantitate levels of MDAM and its major metabolite, 7-hydroxy-γ-methylene-10-deazaaminopterin (7-OH-MDAM), in human plasma. The recovery of MDAM and 7-OH-MDAM from plasma was >97% by a simple one-step deproteinization process using tetrabutylammonium bromide (TBABr) and methanol. MDAM and 7-OH-MDAM remained stable in plasma over a 28-day test period at ambient temperatures, and neither compound was light-sensitive. The limit of quantitation was 0.005 μM for both MDAM and 7-OH-MDAM. This assay has been found to be simple, sensitive and reproducible in determining plasma concentrations of MDAM and 7-OH-MDAM in patients with solid cancers in a phase trial.

AB - γ-Methylene-10-deazaaminopterin (MDAM), a unique dihydrofolate reductase inhibitor, has demonstrated antitumor activity against a broad spectrum of human solid tumors in preclinical studies. A novel reversed-phase, ion-pair high-performance liquid chromatography (HPLC) assay that uses fluorescence detection has been developed to quantitate levels of MDAM and its major metabolite, 7-hydroxy-γ-methylene-10-deazaaminopterin (7-OH-MDAM), in human plasma. The recovery of MDAM and 7-OH-MDAM from plasma was >97% by a simple one-step deproteinization process using tetrabutylammonium bromide (TBABr) and methanol. MDAM and 7-OH-MDAM remained stable in plasma over a 28-day test period at ambient temperatures, and neither compound was light-sensitive. The limit of quantitation was 0.005 μM for both MDAM and 7-OH-MDAM. This assay has been found to be simple, sensitive and reproducible in determining plasma concentrations of MDAM and 7-OH-MDAM in patients with solid cancers in a phase trial.

KW - γ-Methylene-10-deazaaminopterin

KW - 7-hydroxy-γ-methylene-10-deazaaminopterin

UR - http://www.scopus.com/inward/record.url?scp=0030877275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030877275&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(97)00205-3

DO - 10.1016/S0378-4347(97)00205-3

M3 - Article

C2 - 9300877

AN - SCOPUS:0030877275

VL - 695

SP - 401

EP - 408

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 0378-4347

IS - 2

ER -